Ionis and AstraZeneca's Phase 3 trial for ATTR-CM falls short of expectations

In brief

A creator-ready AI video script about Ionis and AstraZeneca's Phase 3 trial for ATTR-CM falls short of expectations, written in clear everyday wording from 1 recent source.